Cargando…

Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia

Tardive dyskinesia (TD) is a serious and often irreversible involuntary muscle movement that involves the face, lips, tongue, trunk, and extremities. TD is a risk in the use of antipsychotic medications, whether it is typical or first generation or atypical or second-generation antipsychotic. The ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Maria Ruiza, Espiridion, Eduardo D, Gurski, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045975/
https://www.ncbi.nlm.nih.gov/pubmed/32140359
http://dx.doi.org/10.7759/cureus.6801
_version_ 1783501882276184064
author Yee, Maria Ruiza
Espiridion, Eduardo D
Gurski, John
author_facet Yee, Maria Ruiza
Espiridion, Eduardo D
Gurski, John
author_sort Yee, Maria Ruiza
collection PubMed
description Tardive dyskinesia (TD) is a serious and often irreversible involuntary muscle movement that involves the face, lips, tongue, trunk, and extremities. TD is a risk in the use of antipsychotic medications, whether it is typical or first generation or atypical or second-generation antipsychotic. The risk is highest in patients receiving long-term antipsychotic treatment. Before the availability of valbenazine, clozapine was used to reverse or at least ameliorate TD. We report a case of a patient on long-term antipsychotic treatment whose TD was initially reversed by clozapine but was completely reversed by valbenazine.
format Online
Article
Text
id pubmed-7045975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70459752020-03-05 Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia Yee, Maria Ruiza Espiridion, Eduardo D Gurski, John Cureus Psychiatry Tardive dyskinesia (TD) is a serious and often irreversible involuntary muscle movement that involves the face, lips, tongue, trunk, and extremities. TD is a risk in the use of antipsychotic medications, whether it is typical or first generation or atypical or second-generation antipsychotic. The risk is highest in patients receiving long-term antipsychotic treatment. Before the availability of valbenazine, clozapine was used to reverse or at least ameliorate TD. We report a case of a patient on long-term antipsychotic treatment whose TD was initially reversed by clozapine but was completely reversed by valbenazine. Cureus 2020-01-28 /pmc/articles/PMC7045975/ /pubmed/32140359 http://dx.doi.org/10.7759/cureus.6801 Text en Copyright © 2020, Yee et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychiatry
Yee, Maria Ruiza
Espiridion, Eduardo D
Gurski, John
Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
title Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
title_full Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
title_fullStr Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
title_full_unstemmed Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
title_short Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
title_sort use of valbenazine in a 54-year-old female with severe tardive dyskinesia
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045975/
https://www.ncbi.nlm.nih.gov/pubmed/32140359
http://dx.doi.org/10.7759/cureus.6801
work_keys_str_mv AT yeemariaruiza useofvalbenazineina54yearoldfemalewithseveretardivedyskinesia
AT espiridioneduardod useofvalbenazineina54yearoldfemalewithseveretardivedyskinesia
AT gurskijohn useofvalbenazineina54yearoldfemalewithseveretardivedyskinesia